(Taken directly from the application) The endochondral developmental program is four dimensional, one in which spatial relationships among its cells change over time. This proposal focuses on understanding the roles the PTHrP and IHH systems and their secondary mediators play in this complex process, both individually and through effects each system has on the other. Both PTHrP and IHH have strong, but distinguishable influences on this process. Also, there is evidence that PTHrP may mediate some but not all of the actions of IHH, and that the two systems are participants in a feedback system within the developing bone. Our approach takes advantage of genetically-altered mice models: mice null for genes encoding PTHrP, its receptor, or IHH. It also features study of murine hindlimb explants in vitro, where chondrocytic development faithfully mimics in vivo events, and use of carrier beads embedded in explants to deliver local gradients of factors.
Aim I determines the molecules involved in mediating IHH's actions and the interrelationships among these mediators.
Aim II tests the hypothesis that PTHrP antagonizes IHH signaling in IHH-target cells.
Aim III characterizes the roles PTHrP plays in cartilage biology in addition to its role in delaying differentiation, i.e. stimulation of chondrocyte proliferation and actions as a competence factor. These fundamental inquiries into endochondral bone biology have important implications for human disease: deficiencies in genes from the hedgehog signaling pathway have been implicated in such varied conditions as nevoid basal cell carcinoma syndrome and Greig cephalopolysyndactyly syndrome, Jansen's metaphyseal dysplasia is the consequence of a constitutively-active PTH/PTHrP receptor. Furthermore, IHH is the only hedgehog family member whose expression is found postnatally in the skeleton, and the IHH and PTHrP systems as well as their putative secondary mediators have also been shown to be active in fracture repair in adults. Increasing understanding of fundamental issues regarding cartilage biology will yield insight for more rational approaches for treating children with short stature and potentially for treating bone loss diseases, such as osteoporosis.

Project Start
1999-04-15
Project End
1999-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
31
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Christov, Marta; Clark, Abbe R; Corbin, Braden et al. (2018) Inducible podocyte-specific deletion of CTCF drives progressive kidney disease and bone abnormalities. JCI Insight 3:
Dedic, Christopher; Hung, Tin Shing; Shipley, Alan M et al. (2018) Calcium fluxes at the bone/plasma interface: Acute effects of parathyroid hormone (PTH) and targeted deletion of PTH/PTH-related peptide (PTHrP) receptor in the osteocytes. Bone 116:135-143
Mizuhashi, Koji; Ono, Wanida; Matsushita, Yuki et al. (2018) Resting zone of the growth plate houses a unique class of skeletal stem cells. Nature 563:254-258
Hanna, Patrick; Grybek, Virginie; Perez de Nanclares, Guiomar et al. (2018) Genetic and Epigenetic Defects at the GNAS Locus Lead to Distinct Patterns of Skeletal Growth but Similar Early-Onset Obesity. J Bone Miner Res 33:1480-1488
Wein, Marc N; Foretz, Marc; Fisher, David E et al. (2018) Salt-Inducible Kinases: Physiology, Regulation by cAMP, and Therapeutic Potential. Trends Endocrinol Metab 29:723-735
Bastepe, Murat (2018) GNAS mutations and heterotopic ossification. Bone 109:80-85
Roszko, Kelly L; Bi, Ruiye; Gorvin, Caroline M et al. (2017) Knockin mouse with mutant G?11 mimics human inherited hypocalcemia and is rescued by pharmacologic inhibitors. JCI Insight 2:e91079
Grigelioniene, Giedre; Nevalainen, Pasi I; Reyes, Monica et al. (2017) A Large Inversion Involving GNAS Exon A/B and All Exons Encoding Gs? Is Associated With Autosomal Dominant Pseudohypoparathyroidism Type Ib (PHP1B). J Bone Miner Res 32:776-783
Balani, Deepak H; Ono, Noriaki; Kronenberg, Henry M (2017) Parathyroid hormone regulates fates of murine osteoblast precursors in vivo. J Clin Invest 127:3327-3338
Cheloha, Ross W; Chen, Bingming; Kumar, Niyanta N et al. (2017) Development of Potent, Protease-Resistant Agonists of the Parathyroid Hormone Receptor with Broad ? Residue Distribution. J Med Chem 60:8816-8833

Showing the most recent 10 out of 215 publications